Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Stroke, Migraine and Patent Foramen Ovale Not Necessarily Temporary Associated

Cryptogenic stroke patients with migraine have high prevalence (79%) of patent foramen ovale (PFO) with right to left shunt. However, the timing of stroke in migraineurs is not usually associated to a migraine attack. These observations are consistent with the hypothesis that the most likely mechanism of stroke in these patients with migraine is a paradoxical embolus.

Stroke criptogénico y el fin de la controversia sobre el cierre del foramen ovalWe know that individuals with migraine have a higher risk of stroke than the general population, but the problem is we do not have a clear physiopathology of this increased risk yet.

 

Given the frequent association between intra-cardiac shunt and migraine, paradoxical embolus has been proposed as a hypothesis to explain stroke in patients with PFO or intra-pulmonary arteriovenous malformations. The aim of this study was to determine the prevalence of PFO with right to left shunt in patients with cryptogenic stroke and a history of migraine.


Read also: We Should Consider Mitral Stenosis Before TAVR.


All patients presenting with ischemic stroke were characterized based on the ASCOD (atherosclerosis, small vessels disease, heart disease, others, dissection). Migraine diagnosis was done retrospectively, and aura was frequent (50% of the attacks). PFO diagnosis with right to left shunt was determined by a positive a bubble contrast study, either with transcranial doppler, transthoracic or transesophageal echocardiography.

 

Of 712 patients with ischemic stroke included in this study, 18% (127) were diagnosed as cryptogenic stroke and, of these patients, more than half (68 patients) had PFO and a history of migraine.

 

There was a high rate of PFO (79%) in patients with migraine and cryptogenic stroke and an even higher rate (93%) when migraine had an aura.


Read also: Morbidity and Mortality During Authorization Wait-Times for TAVR.


Only 5 patients (4%) had a history compatible with migraine infarction.

 

Conclusion

In patients with cryptogenic shock with migraine, there is high prevalence of patent foramen ovale with right to left shunt. The timing of stroke is normally not associated with a migraine attack, which is why these patients’ most likely physiopathological mechanism is a paradoxical embolus, as in those not presenting migraine. Future classification of cryptogenic stroke should consider patent foramen ovale as a separate etiological category.

 

Original title: Frequency of Patent Foramen Ovale and Migraine in Patients with Cryptogenic Stroke.

Reference: Brian H. West et al. Stroke. 2018;49:00-00.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...